{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:30:41Z","timestamp":1790267441874,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671971"],"award-info":[{"award-number":["81671971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772172"],"award-info":[{"award-number":["81772172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871641"],"award-info":[{"award-number":["81871641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1602223"],"award-info":[{"award-number":["U1602223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project of Beijing Natural Science Foundation","award":["KZ201810025035"],"award-info":[{"award-number":["KZ201810025035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2019,6,18]]},"DOI":"10.1007\/s00253-019-09798-9","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T06:05:17Z","timestamp":1556517917000},"page":"4977-4986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice"],"prefix":"10.1007","volume":"103","author":[{"given":"Na","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"issue":"34","key":"9798_CR1","first-page":"421","volume":"90","author":"World Health Organization","year":"2015","unstructured":"World Health Organization (2015) Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015(1). Safety of CYD-TDV dengue vaccine. Wkly Epidemiol Rec 90(34):421\u2013423","journal-title":"Wkly Epidemiol Rec"},{"key":"9798_CR2","doi-asserted-by":"publisher","unstructured":"World Health Organization (2018) Dengue vaccine: WHO position paper, September 2018 - Recommendations. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.063","DOI":"10.1016\/j.vaccine.2018.09.063"},{"key":"9798_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcv.2018.09.020","volume":"108","author":"JH Aberle","year":"2018","unstructured":"Aberle JH, Koblischke M, Stiasny K (2018) CD4 T cell responses to flaviviruses. J Clin Virol 108:126\u2013131. https:\/\/doi.org\/10.1016\/j.jcv.2018.09.020","journal-title":"J Clin Virol"},{"issue":"2","key":"9798_CR4","doi-asserted-by":"publisher","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","volume":"6","author":"SJ Balsitis","year":"2010","unstructured":"Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6(2):e1000790. https:\/\/doi.org\/10.1371\/journal.ppat.1000790","journal-title":"PLoS Pathog"},{"issue":"7446","key":"9798_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496(7446):504\u2013507. https:\/\/doi.org\/10.1038\/nature12060","journal-title":"Nature"},{"issue":"9951","key":"9798_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN, Luong CQ, Rusmil K, Wirawan DN, Nallusamy R, Pitisuttithum P, Thisyakorn U, Yoon IK, van der Vliet D, Langevin E, Laot T, Hutagalung Y, Frago C, Boaz M, Wartel TA, Tornieporth NG, Saville M, Bouckenooghe A (2014) Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384(9951):1358\u20131365. https:\/\/doi.org\/10.1016\/S0140-6736(14)61060-6","journal-title":"Lancet"},{"issue":"4","key":"9798_CR7","doi-asserted-by":"publisher","first-page":"e34602","DOI":"10.1371\/journal.pone.0034602","volume":"7","author":"H Chen","year":"2012","unstructured":"Chen H, Gao N, Fan D, Wu J, Zhu J, Li J, Wang J, Chen Y, An J (2012) Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice. PLoS One 7(4):e34602. https:\/\/doi.org\/10.1371\/journal.pone.0034602","journal-title":"PLoS One"},{"key":"9798_CR8","doi-asserted-by":"publisher","first-page":"30648","DOI":"10.1038\/srep30648","volume":"6","author":"CY Chiang","year":"2016","unstructured":"Chiang CY, Pan CH, Chen MY, Hsieh CH, Tsai JP, Liu HH, Liu SJ, Chong P, Leng CH, Chen HW (2016) Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice. Sci Rep 6:30648. https:\/\/doi.org\/10.1038\/srep30648","journal-title":"Sci Rep"},{"issue":"2","key":"9798_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1586\/14760584.2016.1123097","volume":"15","author":"K Chokephaibulkit","year":"2016","unstructured":"Chokephaibulkit K, Houillon G, Feroldi E, Bouckenooghe A (2016) Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV(R)) in children. Expert Rev Vaccines 15(2):153\u2013166. https:\/\/doi.org\/10.1586\/14760584.2016.1123097","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"9798_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","volume":"23","author":"BA Coller","year":"2011","unstructured":"Coller BA, Clements DE (2011) Dengue vaccines: progress and challenges. Curr Opin Immunol 23(3):391\u2013398. https:\/\/doi.org\/10.1016\/j.coi.2011.03.005","journal-title":"Curr Opin Immunol"},{"issue":"Pt 4","key":"9798_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1099\/vir.0.82640-0","volume":"88","author":"WD Crill","year":"2007","unstructured":"Crill WD, Trainor NB, Chang GJ (2007) A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol 88(Pt 4):1169\u20131174. https:\/\/doi.org\/10.1099\/vir.0.82640-0","journal-title":"J Gen Virol"},{"issue":"5979","key":"9798_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328(5979):745\u2013748. https:\/\/doi.org\/10.1126\/science.1185181","journal-title":"Science"},{"issue":"1","key":"9798_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/tra.12012","volume":"14","author":"J Flipse","year":"2013","unstructured":"Flipse J, Wilschut J, Smit JM (2013) Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic 14(1):25\u201335. https:\/\/doi.org\/10.1111\/tra.12012","journal-title":"Traffic"},{"issue":"1","key":"9798_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.imlet.2009.12.023","volume":"129","author":"N Gao","year":"2010","unstructured":"Gao N, Chen W, Zheng Q, Fan DY, Zhang JL, Chen H, Gao GF, Zhou DS, An J (2010) Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination. Immunol Lett 129(1):23\u201331. https:\/\/doi.org\/10.1016\/j.imlet.2009.12.023","journal-title":"Immunol Lett"},{"key":"9798_CR15","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.4049\/jimmunol.1600927","volume":"197","author":"L Gil","year":"2016","unstructured":"Gil L, Cobas K, Lazo L, Marcos E, Hernandez L, Suzarte E, Izquierdo A, Valdes I, Blanco A, Puentes P, Romero Y, Perez Y, Guzman MG, Guillen G, Hermida L (2016) A tetravalent formulation based on recombinant nucleocapsid-like particles from dengue viruses induces a functional immune response in mice and monkeys. J Immunol 197:3597\u20133606. https:\/\/doi.org\/10.4049\/jimmunol.1600927","journal-title":"J Immunol"},{"key":"9798_CR16","doi-asserted-by":"publisher","unstructured":"Grifoni A, Pham J, Sidney J, O\u2019Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE, Jr., Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A (2017) Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans. J Virol doi:https:\/\/doi.org\/10.1128\/JVI.01469-17, 91","DOI":"10.1128\/JVI.01469-17"},{"issue":"9","key":"9798_CR17","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, Lang J, Ocran S, Mitchell F, Parsons M, Brown N, Brandler S, Fournier C, Barrere B, Rizvi F, Travassos A, Nichols R, Trent D, Monath T (2004) Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol 78(9):4761\u20134775","journal-title":"J Virol"},{"issue":"9599","key":"9798_CR18","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","volume":"370","author":"SB Halstead","year":"2007","unstructured":"Halstead SB (2007) Dengue. Lancet 370(9599):1644\u20131652. https:\/\/doi.org\/10.1016\/S0140-6736(07)61687-0","journal-title":"Lancet"},{"issue":"1","key":"9798_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","volume":"32","author":"SB Halstead","year":"1983","unstructured":"Halstead SB, Rojanasuphot S, Sangkawibha N (1983) Original antigenic sin in dengue. Am J Trop Med Hyg 32(1):154\u2013156","journal-title":"Am J Trop Med Hyg"},{"issue":"29","key":"9798_CR20","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","volume":"30","author":"FX Heinz","year":"2012","unstructured":"Heinz FX, Stiasny K (2012) Flaviviruses and flavivirus vaccines. Vaccine 30(29):4301\u20134306. https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.114","journal-title":"Vaccine"},{"issue":"36","key":"9798_CR21","doi-asserted-by":"publisher","first-page":"E8378","DOI":"10.1073\/pnas.1714250115","volume":"115","author":"M Juraska","year":"2018","unstructured":"Juraska M, Magaret CA, Shao J, Carpp LN, Fiore-Gartland AJ, Benkeser D, Girerd-Chambaz Y, Langevin E, Frago C, Guy B, Jackson N, Duong Thi Hue K, Simmons CP, Edlefsen PT, Gilbert PB (2018) Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials. Proc Natl Acad Sci U S A 115(36):E8378\u2013E8387. https:\/\/doi.org\/10.1073\/pnas.1714250115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9798_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.11599\/germs.2013.1034","volume":"3","author":"KH Khan","year":"2013","unstructured":"Khan KH (2013) DNA vaccines: roles against diseases. Germs 3(1):26\u201335. https:\/\/doi.org\/10.11599\/germs.2013.1034","journal-title":"Germs"},{"issue":"3","key":"9798_CR23","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/jvi.67.3.1672-1675.1993","volume":"67","author":"E Konishi","year":"1993","unstructured":"Konishi E, Mason PW (1993) Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol 67(3):1672\u20131675","journal-title":"J Virol"},{"issue":"13","key":"9798_CR24","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1128\/JVI.00316-08","volume":"82","author":"CY Lai","year":"2008","unstructured":"Lai CY, Tsai WY, Lin SR, Kao CL, Hu HP, King CC, Wu HC, Chang GJ, Wang WK (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82(13):6631\u20136643. https:\/\/doi.org\/10.1128\/JVI.00316-08","journal-title":"J Virol"},{"issue":"38","key":"9798_CR25","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1016\/j.vaccine.2013.06.099","volume":"31","author":"J Li","year":"2013","unstructured":"Li J, Chen H, Wu N, Fan D, Liang G, Gao N, An J (2013a) Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice. Vaccine 31(38):4136\u20134142. https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.099","journal-title":"Vaccine"},{"key":"9798_CR26","doi-asserted-by":"publisher","first-page":"19953","DOI":"10.1038\/srep19953","volume":"6","author":"J Li","year":"2016","unstructured":"Li J, Gao N, Fan D, Chen H, Sheng Z, Fu S, Liang G, An J (2016) Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice. Sci Rep 6:19953. https:\/\/doi.org\/10.1038\/srep19953","journal-title":"Sci Rep"},{"issue":"24","key":"9798_CR27","doi-asserted-by":"publisher","first-page":"13694","DOI":"10.1128\/JVI.00931-13","volume":"87","author":"XF Li","year":"2013","unstructured":"Li XF, Deng YQ, Yang HQ, Zhao H, Jiang T, Yu XD, Li SH, Ye Q, Zhu SY, Wang HJ, Zhang Y, Ma J, Yu YX, Liu ZY, Li YH, Qin ED, Shi PY, Qin CF (2013b) A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates. J Virol 87(24):13694\u201313705. https:\/\/doi.org\/10.1128\/JVI.00931-13","journal-title":"J Virol"},{"key":"9798_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.virusres.2014.07.017","volume":"191","author":"Z Li","year":"2014","unstructured":"Li Z, Yang H, Yang J, Lin H, Wang W, Liu L, Zhao Y, Zeng X, Yu Y, Li Y (2014) Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone. Virus Res 191:10\u201320. https:\/\/doi.org\/10.1016\/j.virusres.2014.07.017","journal-title":"Virus Res"},{"issue":"6","key":"9798_CR29","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1128\/JVI.02273-08","volume":"83","author":"M Lobigs","year":"2009","unstructured":"Lobigs M, Larena M, Alsharifi M, Lee E, Pavy M (2009) Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus. J Virol 83(6):2436\u20132445. https:\/\/doi.org\/10.1128\/JVI.02273-08","journal-title":"J Virol"},{"issue":"3","key":"9798_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/649916","volume":"201","author":"D Morrison","year":"2010","unstructured":"Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, Lang J (2010) A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. J Infect Dis 201(3):370\u2013377. https:\/\/doi.org\/10.1086\/649916","journal-title":"J Infect Dis"},{"key":"9798_CR31","doi-asserted-by":"publisher","first-page":"28688","DOI":"10.1038\/srep28688","volume":"6","author":"R Saga","year":"2016","unstructured":"Saga R, Fujimoto A, Watanabe N, Matsuda M, Hasegawa M, Watashi K, Aizaki H, Nakamura N, Tajima S, Takasaki T, Konishi E, Kato T, Kohara M, Takeyama H, Wakita T, Suzuki R (2016) Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus. Sci Rep 6:28688. https:\/\/doi.org\/10.1038\/srep28688","journal-title":"Sci Rep"},{"issue":"1","key":"9798_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12879-016-1873-8","volume":"16","author":"Y Saito","year":"2016","unstructured":"Saito Y, Moi ML, Takeshita N, Lim CK, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T (2016) Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis 16(1):578. https:\/\/doi.org\/10.1186\/s12879-016-1873-8","journal-title":"BMC Infect Dis"},{"issue":"47","key":"9798_CR33","doi-asserted-by":"publisher","first-page":"8669","DOI":"10.1016\/j.vaccine.2011.08.117","volume":"29","author":"E Schuller","year":"2011","unstructured":"Schuller E, Klingler A, Dubischar-Kastner K, Dewasthaly S, Muller Z (2011) Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R)). Vaccine 29(47):8669\u20138676. https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.117","journal-title":"Vaccine"},{"issue":"47","key":"9798_CR34","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1016\/j.vaccine.2016.10.001","volume":"34","author":"Z Sheng","year":"2016","unstructured":"Sheng Z, Gao N, Cui X, Fan D, Chen H, Wu N, Wei J, An J (2016) Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs. Vaccine 34(47):5751\u20135757. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.001","journal-title":"Vaccine"},{"issue":"2","key":"9798_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/1348-0421.12125","volume":"58","author":"F Sjatha","year":"2014","unstructured":"Sjatha F, Kuwahara M, Sudiro TM, Kameoka M, Konishi E (2014) Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response. Microbiol Immunol 58(2):126\u2013134. https:\/\/doi.org\/10.1111\/1348-0421.12125","journal-title":"Microbiol Immunol"},{"issue":"19","key":"9798_CR36","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1128\/JVI.00080-06","volume":"80","author":"K Stiasny","year":"2006","unstructured":"Stiasny K, Kiermayr S, Holzmann H, Heinz FX (2006) Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 80(19):9557\u20139568. https:\/\/doi.org\/10.1128\/JVI.00080-06","journal-title":"J Virol"},{"key":"9798_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep34215","volume":"6","author":"G Swaminathan","year":"2016","unstructured":"Swaminathan G, Thoryk EA, Cox KS, Smith JS, Wolf JJ, Gindy ME, Casimiro DR, Bett AJ (2016) A tetravalent sub-unit dengue vaccine formulated with ionizable cationic lipid nanoparticle induces significant immune responses in rodents and non-human primates. Sci Rep 6:34215. https:\/\/doi.org\/10.1038\/srep34215","journal-title":"Sci Rep"},{"issue":"7","key":"9798_CR38","doi-asserted-by":"publisher","first-page":"e0003903","DOI":"10.1371\/journal.pntd.0003903","volume":"9","author":"CT Tang","year":"2015","unstructured":"Tang CT, Li PC, Liu IJ, Liao MY, Chiu CY, Chao DY, Wu HC (2015) An epitope-substituted DNA vaccine improves safety and immunogenicity against Dengue virus type 2. PLoS Negl Trop Dis 9(7):e0003903. https:\/\/doi.org\/10.1371\/journal.pntd.0003903","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"9798_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3201\/eid0803.010238","volume":"8","author":"RB Tesh","year":"2002","unstructured":"Tesh RB, Travassos da Rosa AP, Guzman H, Araujo TP, Xiao SY (2002) Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 8(3):245\u2013251. https:\/\/doi.org\/10.3201\/eid0803.010238","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"9798_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/QCO.0b013e32834a1b0b","volume":"24","author":"SJ Thomas","year":"2011","unstructured":"Thomas SJ, Endy TP (2011) Critical issues in dengue vaccine development. Curr Opin Infect Dis 24(5):442\u2013450. https:\/\/doi.org\/10.1097\/QCO.0b013e32834a1b0b","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"9798_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.virol.2006.10.033","volume":"360","author":"NB Trainor","year":"2007","unstructured":"Trainor NB, Crill WD, Roberson JA, Chang GJ (2007) Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology 360(2):398\u2013406. https:\/\/doi.org\/10.1016\/j.virol.2006.10.033","journal-title":"Virology"},{"issue":"12","key":"9798_CR42","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/v3122374","volume":"3","author":"WM Wahala","year":"2011","unstructured":"Wahala WM, Silva AM (2011) The human antibody response to dengue virus infection. Viruses 3(12):2374\u20132395. https:\/\/doi.org\/10.3390\/v3122374","journal-title":"Viruses"},{"issue":"22","key":"9798_CR43","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1007\/s00253-015-6819-3","volume":"99","author":"Y Wang","year":"2015","unstructured":"Wang Y, Si L, Luo Y, Guo X, Zhou J, Fang D, Yan H, Zeng G, Jiang L (2015) Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection. Appl Microbiol Biotechnol 99(22):9685\u20139698. https:\/\/doi.org\/10.1007\/s00253-015-6819-3","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"9798_CR44","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","volume":"8","author":"J Wen","year":"2017","unstructured":"Wen J, Elong Ngono A, Regla-Nava JA, Kim K, Gorman MJ, Diamond MS, Shresta S (2017) Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge. Nat Commun 8(1):1459. https:\/\/doi.org\/10.1038\/s41467-017-01669-z","journal-title":"Nat Commun"},{"issue":"21","key":"9798_CR45","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","volume":"28","author":"Y Yu","year":"2010","unstructured":"Yu Y (2010) Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 28(21):3635\u20133641. https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.105","journal-title":"Vaccine"},{"issue":"1","key":"9798_CR46","doi-asserted-by":"publisher","first-page":"e86573","DOI":"10.1371\/journal.pone.0086573","volume":"9","author":"H Zhao","year":"2014","unstructured":"Zhao H, Jiang T, Zhou XZ, Deng YQ, Li XF, Chen SP, Zhu SY, Zhou X, Qin ED, Qin CF (2014) Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine. PLoS One 9(1):e86573. https:\/\/doi.org\/10.1371\/journal.pone.0086573","journal-title":"PLoS One"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-019-09798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-019-09798-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-019-09798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:15:25Z","timestamp":1744175725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-019-09798-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,6,18]]}},"alternative-id":["9798"],"URL":"https:\/\/doi.org\/10.1007\/s00253-019-09798-9","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the animal ethics committees of Capital Medical University, Beijing, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}